Rationale for the prevention of syncope trial IV: Assessment of midodrine

Clinical Autonomic Research

Volumn 22, Issue 6, 2012, Pages 275-280

  Raj, Satish R ^a   Faris, Peter D ^b   McRae, Maureen ^c   Sheldon, Robert S ^c  

^a VANDERBILT UNIVERSITY   (United States)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Quality of life; Randomized clinical trial; Vasovagal syncope

Indexed keywords

MIDODRINE; PLACEBO;

ARTICLE; DRUG DOSE TITRATION; FAINTNESS; FOLLOW UP; HUMAN; HYPOTHESIS; INTENTION TO TREAT ANALYSIS; MULTICENTER STUDY (TOPIC); PRESYNCOPE; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK FACTOR; STUDY DESIGN;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; HUMANS; INTENTION TO TREAT ANALYSIS; MIDODRINE; MULTICENTER STUDIES AS TOPIC; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SYNCOPE, VASOVAGAL; TREATMENT OUTCOME;

EID: 84872114280     PISSN: 09599851     EISSN: 16191560     Source Type: Journal    
DOI: 10.1007/s10286-012-0167-5     Document Type: Article

References (33)

1. Connolly SJ, Sheldon R, Roberts RS, Gent M (1999) The North American vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16-20 (Pubitemid 29064066)
2. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second vasovagal pacemaker study (VPS II): a randomized trial. JAMA 289:2224-2229 (Pubitemid 37430190)
3. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van DN (2006) Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 17:1172-1176 (Pubitemid 44583857)
4. Kaufmann H, Saadia D, Voustianiouk A (2002) Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 52:342-345 (Pubitemid 35001501)
5. Lamarre-Cliche M, Souich P, Champlain J, Larochelle P (2008) Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, twoperiod, crossover, placebo-controlled study. Clin Ther 30:1629-1638
6. Malik P, Koshman ML, Sheldon R (1997) Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result. J Am Coll Cardiol 29:1284-1289 (Pubitemid 27201947)
7. Manyari DE, Rose S, Tyberg JV, Sheldon RS (1996) Abnormal reflex venous function in patients with neuromediated syncope. J Am Coll Cardiol 27:1730-1735 (Pubitemid 26198027)
8. Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen KU, Kuusela TA, Diedrich AM (1997) Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation 96:2509-2513 (Pubitemid 27451338)
9. Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D (1997) Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 99:2736-2744 (Pubitemid 27259821)
10. Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R (2000) The elusive pathophysiology of neurally mediated syncope. Circulation 102:2898-2906
11. Olde Nordkamp LR, van DN, Ganzeboom KS, Reitsma JB, Luitse JS, Dekker LR, Shen WK, Wieling W (2009) Syncope prevalence in the ED compared to general practice and population: a strong selection process. Am J Emerg Med 27:271-279
12. Olshansky B (2007) Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship. J Am Coll Cardiol 49:415-421 (Pubitemid 46135884)
13. Perez-Lugones A, Schweikert R, Pavia S, Sra J, Akhtar M, Jaeger F, Tomassoni GF, Saliba W, Leonelli FM, Bash D, Beheiry S, Shewchik J, Tchou PJ, Natale A (2001) Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 12:935-938 (Pubitemid 32751906)
14. Posch W, Lindner W (1989) Quantification of midodrine and its active metabolite in plasma using a high performance liquid chromatography column switching technique. Biomed Chromatogr 3:153-156 (Pubitemid 19211697)
15. Qingyou Z, Junbao D, Chaoshu T (2006) The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr 149:777-780 (Pubitemid 44816338)
16. Raj SR, Rose S, Ritchie D, Sheldon RS (2006) The Second Prevention of Syncope Trial (POST II) - a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 151:1186-1187
17. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99:1452-1457 (Pubitemid 29140911)
18. Romme JJ, van DN, Go-Schon IK, Reitsma JB, Wieling W (2011) Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace 13:1639-1647
19. Rose MS, Koshman ML, Ritchie D, Sheldon R (2009) The development and preliminary validation of a scale measuring the impact of syncope on quality of life. Europace 11:1369-1374
20. Rose MS, Koshman ML, Spreng S, Sheldon R (2000) The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol 53:1209-1216 (Pubitemid 32007836)
21. Serletis A, Rose S, Sheldon AG, Sheldon RS (2006) Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 27:1965-1970 (Pubitemid 44297371)
22. Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M, Ku T, Fouad-Tarazi F, Ritchie D, Koshman ML (2006) Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113:1164-1170
23. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S (1998) Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 81:158-162 (Pubitemid 28057198)
24. Sheldon R, Rose S, Connolly S (2003) Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design. Europace 5:71-75
25. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M (2006) Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 27:344-350 (Pubitemid 43100031)
26. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 93:973-981 (Pubitemid 26074835)
27. Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Sheldon A, Koshman ML, Ritchie D (2009) Design and use of a quantitative scale for measuring presyncope. J Cardiovasc Electrophysiol 20:888-893
28. Stewart JM, McLeod KJ, Sanyal S, Herzberg G, Montgomery LD (2004) Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents. Circulation 110:2575-2581 (Pubitemid 39453004)
29. Sun BC, Emond JA, Camargo CA Jr (2005) Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol 95:668-671 (Pubitemid 40255267)
30. Verheyden B, Liu J, van DN, Westerhof BE, Reybrouck T, Aubert AE, Wieling W (2008) Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerineinduced orthostatic vasovagal syncope. Heart Rhythm 5:1695-1701
31. Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45-49 (Pubitemid 28179062)
32. Yamazaki R, Tsuchida K, Aihara H (1987) Effects of midodrine on experimentally induced postural hypotension and venous pooling in dogs. Res Commun Chem Pathol Pharmacol 58:323-337 (Pubitemid 18021017)
33. Yamazaki R, Tsuchida K, Aihara H (1988) Effects of alphaadrenoceptor agonists on cardiac output and blood pressure in spinally anesthetized ganglion-blocked dogs. Arch Int Pharmacodyn Ther 295:80-93